{{Rsnum
|rsid=1938901
|Gene=MMP1
|Chromosome=11
|position=102790934
|Orientation=minus
|GMAF=0.3251
|Gene_s=COX6CP3,MMP1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 0.0
| HCB | 22.9 | 34.3 | 42.9
| JPT | 15.9 | 65.9 | 18.2
| YRI | 68.6 | 31.4 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 22.9 | 34.3 | 42.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID|18483334}} 635 lung cancer cases with onset of disease below 51 years of age and 1,300 controls.  major alleles associated with increased in risk of early-onset [[lung cancer]] modified by [[smoking]].
*[[rs1938901]] (P = 0.0089)
*[[rs193008]] (P = 0.0108)
*[[rs996999]] (P = 0.0459). For rs996999, significance vanished after correction for multiple testing. 
odds ratio between 1.2 and 1.3 (95% confidence interval, 1.0-1.5)

{{PMID Auto
|PMID=19318431
|Title=No association between matrix metalloproteinase-1 or matrix metalloproteinase-3 polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study.
|OA=1
}}

{{PMID Auto
|PMID=19435861
|Title=No association between matrix metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and endometrial cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=20078883
|Title=Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}